Gastrointestinal absorption of drugs: methods and studies
暂无分享,去创建一个
[1] G. Houin,et al. The improved everted gut sac: a simple method to study intestinal P-glycoprotein , 1998 .
[2] H. Junginger,et al. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[3] A. Y. Lu,et al. Role of pharmacokinetics and metabolism in drug discovery and development. , 1997, Pharmacological reviews.
[4] P. Watkins,et al. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. , 1997, Advanced drug delivery reviews.
[5] A. Yamamoto,et al. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment. , 1997, Biological & pharmaceutical bulletin.
[6] H. Lennernäs,et al. Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms , 1997, The Journal of pharmacy and pharmacology.
[7] H Lennernäs,et al. Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models , 1997, The Journal of pharmacy and pharmacology.
[8] P. Artursson,et al. Diffusion of drugs in native and purified gastrointestinal mucus. , 1997, Journal of pharmaceutical sciences.
[9] B. Hirst,et al. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption , 1997 .
[10] D. Thakker,et al. Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium , 1997 .
[11] W. Rubas,et al. The effect of chemical modifications on octanol/water partition (log D) and permeabilities across Caco-2 monolayers , 1997 .
[12] O. H. Chan,et al. Discrimination between drug candidates using models for evaluation of intestinal absorption , 1997 .
[13] Chao-pin Lee,et al. Selection of development candidates based on in vitro permeability measurements , 1997 .
[14] Ismael J. Hidalgo,et al. Carrier-mediated transport and efflux mechanisms in Caco-2 cells , 1996 .
[15] B. Levet-Trafit,et al. Estimation of oral drug absorption in man based on intestine permeability in rats. , 1996, Life sciences.
[16] Leslie Z. Benet,et al. Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery , 1996 .
[17] P. Bhat,et al. The limiting role of mucus in drug absorption : drug permeation through mucus solution , 1995 .
[18] P. Artursson,et al. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. , 1995, The Journal of pharmacology and experimental therapeutics.
[19] Hans Lennernäs,et al. EXPERIMENTAL ESTIMATION OF THE EFFECTIVE UNSTIRRED WATER LAYER THICKNESS IN THE HUMAN JEJUNUM, AND ITS IMPORTANCE IN ORAL-DRUG ABSORPTION , 1995 .
[20] S. Lundin,et al. Different properties of the paracellular pathway account for the regional small intestinal permeability to the peptide desmopressin. , 1995, Journal of pharmaceutical sciences.
[21] P. Macheras,et al. Biopharmaceutics Of Orally Administered Drugs , 1995 .
[22] T. Kissel,et al. Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport , 1995 .
[23] L. Benet,et al. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy , 1995, Molecular carcinogenesis.
[24] R. Kimura,et al. The effect of surgical bowel manipulation and anesthesia on intestinal glucose absorption in rats. , 1995, The Journal of clinical investigation.
[25] P. Artursson,et al. Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption , 1995 .
[26] G. Houin,et al. Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations. , 1995, Medical engineering & physics.
[27] K. Hillgren,et al. In vitro systems for studying intestinal drug absorption , 1995, Medicinal research reviews.
[28] D. Scherman,et al. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. , 1994, Biochemical pharmacology.
[29] J. Kolars,et al. CYP3A gene expression in human gut epithelium. , 1994, Pharmacogenetics.
[30] J. Woodley,et al. The potential use of tomato lectin for oral drug delivery: 2. Mechanism of uptake in vitro , 1994 .
[31] G. Houin,et al. Evidence for a second site of absorption of veralipride in the human small intestine. Use of a new drug delivery telemetric shuttle. , 1994, Arzneimittel-Forschung.
[32] W. L. Chiou. Determination of drug permeability in a flat or distended stirred intestine. Prediction of fraction dose absorbed in humans after oral administration. , 1994, International journal of clinical pharmacology and therapeutics.
[33] G. Houin,et al. Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract. , 1994, Arzneimittel-Forschung.
[34] I. Hidalgo,et al. Uptake and transepithelial transport of the orally absorbed cephalosporin cephalexin, in the human intestinal cell line, Caco-2 , 1994 .
[35] J. Pató,et al. Uptake and transport of poly(N-vinylpyrrolidone-co-maleic acid) by the adult rat small intestine cultured in vitro: Effect of chemical structure , 1994 .
[36] U. Klotz,et al. Extrahepatic Metabolism of Drugs in Humans , 1994, Clinical pharmacokinetics.
[37] Y. Berger,et al. Importance of the paracellular pathway for the transport of a new bisphosphonate using the human CACO-2 monolayers model. , 1993, Biochemical pharmacology.
[38] K. D. Fine,et al. Effect of D-glucose on intestinal permeability and its passive absorption in human small intestine in vivo. , 1993, Gastroenterology.
[39] R. Conradi,et al. Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. , 1993, Biochemical and biophysical research communications.
[40] P. Artursson,et al. Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells. , 1992, Journal of pharmaceutical sciences.
[41] A. Sintov,et al. Chondroitin sulfate: A potential biodegradable carrier for colon-specific drug delivery , 1992 .
[42] H. Saito,et al. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes. , 1992, The Journal of pharmacology and experimental therapeutics.
[43] Hugh N. Nellans,et al. B) Mechanisms of peptide and protein absorption , 1991 .
[44] B. Hirst,et al. Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein. , 1991, British Journal of Cancer.
[45] A. Rubinstein. Microbially controlled drug delivery to the colon , 1990, Biopharmaceutics & drug disposition.
[46] G. Amidon,et al. Passive and carrier-mediated intestinal absorption components of captopril. , 1988, Journal of pharmaceutical sciences.
[47] M. Takano,et al. H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine. , 1988, The Journal of pharmacology and experimental therapeutics.
[48] P. Traber,et al. Expression of cytochrome P450b and P450e genes in small intestinal mucosa of rats following treatment with phenobarbital, polyhalogenated biphenyls, and organochlorine pesticides. , 1988, The Journal of biological chemistry.
[49] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[50] P. Watkins,et al. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. , 1987, The Journal of clinical investigation.
[51] M. L. Gardner,et al. A comparison of the structural integrity of several commonly used preparations of rat small intestine in vitro. , 1987, Clinical science.
[52] R. Rowland,et al. Uptake of free and liposome-entrapped125I-labelled PVP by rat intestinal sacs in vitro: evidence for endocytosis , 1981, Bioscience reports.
[53] J. Woodley,et al. Uptake of free and liposome-entrapped insulin by rat intestinal sacs in vitro , 1981, Bioscience reports.
[54] R. Rowland,et al. Uptake of free and liposome‐entrapped horseradish peroxidase by rat intestinal sacs in vitro , 1981, FEBS letters.
[55] J. Woodley,et al. The uptake of liposome-entrapped 125I-labelled poly(vinylpyrrolidone) by rat jejunum in vitro. , 1978, Biochimica et biophysica acta.
[56] K. Isselbacher,et al. MACROMOLECULAR ABSORPTION , 1972, The Journal of cell biology.
[57] P. Kornguth,et al. Histological reevaluation of everted gut technique for studying intestinal absorption. , 1970, European journal of pharmacology.
[58] T. H. Wilson,et al. The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface , 1954, The Journal of physiology.
[59] H H USSING,et al. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.
[60] X. Boulenc. Intestinal cell models. Their use in evaluating the metabolism and absorption of xenobiotics , 1997 .
[61] G. Russell-Jones. Utilization of the natural mechanism for vitamin B12 uptake for the oral delivery of therapeutics , 1996 .
[62] D. Thakker,et al. USE OF CACO-2 CELLS AS AN IN VITRO INTESTINAL ABSORPTION AND METABOLISM MODEL , 1994 .
[63] M. Gottesman,et al. Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.
[64] A. Zweibaum. Differentiation of Human Colon Cancer Cells , 1991 .
[65] P. Gervasi,et al. Profile of drug-metabolizing enzymes in human ileum and colon. , 1989, Pharmacology.
[66] N. Di Lascio,et al. Tissue distribution of drug-metabolizing enzymes in humans. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.
[67] R. Rowland,et al. The uptake of distearoylphosphatidylcholine/cholesterol liposomes by rat intestinal sacs in vitro. , 1981, Biochimica et biophysica acta.